Gaviscon Suspension *

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 14 September 2021

File name

Gaviscon Oral Suspension PIL_1631636398.pdf

Reasons for updating

  • Change to section 2 - what you need to know - warnings and precautions

Updated on 13 May 2021

File name

Gaviscon Oral Suspension SmPC May21_1620919090.pdf

Reasons for updating

  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to Section 4.8 – Undesirable effects - how to report a side effect

Legal category:Supply through pharmacy only

Updated on 15 January 2020

File name

Gaviscon Oral Susp Aniseed flavour_1579098243.pdf

Reasons for updating

  • New PIL for new product

Updated on 20 April 2016

Reasons for updating

  • New SPC for new product

Legal category:Supply through pharmacy only

Updated on 20 April 2016

Reasons for updating

  • Change to section 6.5 - Nature and contents of container

Legal category:Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

Section 6.4 - 100ml bottle size has been deleted

Updated on 20 April 2016

Reasons for updating

  • Change to section 6.5 - Nature and contents of container

Free text change information supplied by the pharmaceutical company

Section 6.4 - 100ml bottle size has been deleted

Updated on 17 April 2014

Reasons for updating

  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.3 - Contraindications
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.6 - Pregnancy and lactation
  • Change to section 4.7 - Effects on ability to drive and use machines
  • Change to section 4.8 - Undesirable effects
  • Change to section 5.1 - Pharmacodynamic properties
  • Change to section 10 - Date of revision of the text

Legal category:Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

Section 4.2 - added Children under 12 should only be given on medical advice, added information for special patient groups
Section 4.3 - added contraindication for hypersensitivity to active ingredients and excipients
Section 4.4 - added statement regarding calcium and statement to limit treatment duration as much as possible
Section 4.5 - added a 2 hour time interval between taking Gaviscon and other specified products
Section 4.6 - added more detailed information on taking Gaviscon for Pregnancy, breastfeeding, and fertility
Section 4.7 - Updated wording
Section 4.8 -  updated frequencies
Section 5.1 - added pharmacotherapeutic group
Section 10 - Changed Date of revision of text

Updated on 17 April 2014

Reasons for updating

  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.3 - Contraindications
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.6 - Pregnancy and lactation
  • Change to section 4.7 - Effects on ability to drive and use machines
  • Change to section 4.8 - Undesirable effects
  • Change to section 5.1 - Pharmacodynamic properties
  • Change to section 10 - Date of revision of the text

Free text change information supplied by the pharmaceutical company

Section 4.2 - added Children under 12 should only be given on medical advice, added information for special patient groups
Section 4.3 - added contraindication for hypersensitivity to active ingredients and excipients
Section 4.4 - added statement regarding calcium and statement to limit treatment duration as much as possible
Section 4.5 - added a 2 hour time interval between taking Gaviscon and other specified products
Section 4.6 - added more detailed information on taking Gaviscon for Pregnancy, breastfeeding, and fertility
Section 4.7 - Updated wording
Section 4.8 -  updated frequencies
Section 5.1 - added pharmacotherapeutic group
Section 10 - Changed Date of revision of text

Updated on 13 December 2012

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use

Legal category:Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

In section 4.4, added "Contains methyl parahydroxybenzoate (E218) and propyl parahydroxybenzoate (E216) which may cause allergic reactions (possibly delayed).

Updated on 13 December 2012

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use

Free text change information supplied by the pharmaceutical company

In section 4.4, added "Contains methyl parahydroxybenzoate (E218) and propyl parahydroxybenzoate (E216) which may cause allergic reactions (possibly delayed).

Updated on 17 April 2012

Reasons for updating

  • Change to section 9 - Date of renewal of authorisation
  • Change to section 10 - Date of revision of the text

Free text change information supplied by the pharmaceutical company

Updated to amend section 9 to detail date of last renewal to 03/05/2008
Updated to amend section 10 date of revsion of text to September 2008

Updated on 17 April 2012

Reasons for updating

  • Change to section 9 - Date of renewal of authorisation
  • Change to section 10 - Date of revision of the text

Legal category:Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

Updated to amend section 9 to detail date of last renewal to 03/05/2008
Updated to amend section 10 date of revsion of text to September 2008

Updated on 18 December 2008

Reasons for updating

  • Change to section 1 - Name of medicinal product
  • Change to section 9 - Date of renewal of authorisation

Legal category:Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

all changes as a result of license renwal

Updated on 18 December 2008

Reasons for updating

  • Change to section 1 - Name of medicinal product
  • Change to section 9 - Date of renewal of authorisation

Free text change information supplied by the pharmaceutical company

all changes as a result of license renwal

Updated on 15 May 2007

Reasons for updating

  • Change to section 4.8 - Undesirable effects
  • Change to marketing authorisation holder address

Free text change information supplied by the pharmaceutical company

SECTION 4.8.  Allergic manifestations expanded to include anaphylactic and anaphylactoid reactions.
 
SECTION 7.  Change of marketing authorisation holder address to: 7 Riverwalk, Citywest Business Campus, Dublin 24, Ireland.

Updated on 15 May 2007

Reasons for updating

  • Change to section 4.8 - Undesirable effects
  • Change to marketing authorisation holder address

Legal category:Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

SECTION 4.8.  Allergic manifestations expanded to include anaphylactic and anaphylactoid reactions.
 
SECTION 7.  Change of marketing authorisation holder address to: 7 Riverwalk, Citywest Business Campus, Dublin 24, Ireland.

Updated on 01 July 2005

Reasons for updating

  • Change to section 6.3 - Shelf life

Legal category:Supply through pharmacy only

Updated on 01 July 2005

Reasons for updating

  • Change to section 6.3 - Shelf life

Updated on 20 May 2005

Reasons for updating

  • Improved electronic presentation

Legal category:Supply through pharmacy only

Updated on 20 May 2005

Reasons for updating

  • Improved electronic presentation

Updated on 11 August 2004

Reasons for updating

  • Improved electronic presentation

Legal category:Supply through pharmacy only

Updated on 11 August 2004

Reasons for updating

  • Improved electronic presentation

Updated on 16 June 2003

Reasons for updating

  • New SPC for medicines.ie

Legal category:Supply through pharmacy only

Updated on 16 June 2003

Reasons for updating

  • New SPC for medicines.ie